☰

Edgar A Borrego - Publications

Affiliations: 
2017-2022 Biological Sciences University of Texas at El Paso, El Paso, TX, United States 
Area:
Anti-cancer drug discovery
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

8 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Huda MN, Borrego EA, Guerena CD, Varela-Ramirez A, Aguilera RJ, Hamadani CM, Tanner EEL, Badruddoza AZM, Agarwal SK, Nurunnabi M. Topical Administration of an Apoptosis Inducer Mitigates Bleomycin-Induced Skin Fibrosis. Acs Pharmacology & Translational Science. 6: 829-841. PMID 37200808 DOI: 10.1021/acsptsci.3c00039  0.71
2022 Chhikara A, Roayapalley PK, Sakagami H, Amano S, Satoh K, Uesawa Y, Das U, Das S, Borrego EA, Guerena CD, Hernandez CR, Aguilera RJ, Dimmock JR. Novel Unsymmetric 3,5-Bis(benzylidene)-4-piperidones That Display Tumor-Selective Toxicity. Molecules (Basel, Switzerland). 27. PMID 36235258 DOI: 10.3390/molecules27196718  0.74
2022 Huda MN, Deaguro IG, Borrego EA, Kumar R, Islam T, Afrin H, Varela-Ramirez A, Aguilera RJ, Tanner EEL, Nurunnabi M. Ionic liquid-mediated delivery of a BCL-2 inhibitor for topical treatment of skin melanoma. Journal of Controlled Release : Official Journal of the Controlled Release Society. 349: 783-795. PMID 35908622 DOI: 10.1016/j.jconrel.2022.07.035  0.708
2022 Gutierrez DA, Contreras L, Villanueva PJ, Borrego EA, Morán-Santibañez K, Hess JD, DeJesus R, Larragoity M, Betancourt AP, Mohl JE, Robles-Escajeda E, Begum K, Roy S, Kirken RA, Varela-Ramirez A, et al. Identification of a Potent Cytotoxic Pyrazole with Anti-Breast Cancer Activity That Alters Multiple Pathways. Cells. 11. PMID 35053370 DOI: 10.3390/cells11020254  0.739
2021 Contreras L, Medina S, Schiaffino Bustamante AY, Borrego EA, Valenzuela CA, Das U, Karki SS, Dimmock JR, Aguilera RJ. Three novel piperidones exhibit tumor-selective cytotoxicity on leukemia cells via protein degradation and stress-mediated mechanisms. Pharmacological Reports : Pr. PMID 34448104 DOI: 10.1007/s43440-021-00322-3  0.723
2021 Lakhani K, Borrego EA, Cano KG, Dimmock JR, Aguilera RJ, Das S, Roayapalley PK, Sharma RK, Das U. Design, Syntheses, and Bioevaluations of Some Novel -Acryloylbenzohydrazides as Chemostimulants and Cytotoxic Agents. Medicines (Basel, Switzerland). 8. PMID 34205029 DOI: 10.3390/medicines8060027  0.731
2020 Meneses-Brassea BP, Borrego EA, Blazer DS, Sanad MF, Pourmiri S, Gutierrez DA, Varela-Ramirez A, Hadjipanayis GC, El-Gendy AA. Ni-Cu Nanoparticles and Their Feasibility for Magnetic Hyperthermia. Nanomaterials (Basel, Switzerland). 10. PMID 33050215 DOI: 10.3390/nano10101988  0.682
2020 Donoso-Bustamante V, Borrego EA, Schiaffino-Bustamante Y, Gutiérrez DA, Millas-Vargas JP, Fuentes-Retamal S, Correa P, Carrillo I, Aguilera RJ, Miranda D, Chávez-Báez I, Pulgar R, Urra FA, Varela-Ramírez A, Araya-Maturana R. An acylhydroquinone derivative produces OXPHOS uncoupling and sensitization to BH3 mimetic ABT-199 (Venetoclax) in human promyelocytic leukemia cells. Bioorganic Chemistry. 100: 103935. PMID 32454391 DOI: 10.1016/J.Bioorg.2020.103935  0.741
Show low-probability matches.